FCPR Biotechnology Fund
Insider
First SEC filing: May 2, 2014 · Latest: May 2, 2014
Insider at
Insider transactions
0 buys (P)
0 sells (S)
Net: $0
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| May 7, 2014 | SCYX | C | 623,880 | · | · | 0 Direct | -100.00% | Disposed | (price as of 2026-10-06) |
| May 7, 2014 | SCYX | C | 863,672 | · | · | 0 Direct | -100.00% | Disposed | (price as of 2026-10-06) |
| May 7, 2014 | SCYX | C | 313,996 | · | · | 0 Direct | -100.00% | Disposed | (price as of 2026-10-06) |
| May 7, 2014 | SCYX | C | 166,482 | · | · | 0 Direct | -100.00% | Disposed | (price as of 2026-10-06) |
| May 7, 2014 | SCYX | X | 25,998 | · | · | 0 Direct | -100.00% | Disposed | (price as of 2026-10-06) |
| May 7, 2014 | SCYX | X | 5,251 | · | · | 0 Direct | -100.00% | Disposed | (price as of 2026-10-06) |
| May 7, 2014 | SCYX | X | 5,251 | · | · | 0 Direct | -100.00% | Disposed | (price as of 2026-10-06) |
| May 7, 2014 | SCYX | P | 50,000 | $10.00 | $500,000 | 295,077 Direct | +20.40% | Acquired | -99.4% (price as of 2026-10-06) |
| May 7, 2014 | SCYX | C | 30,582 | · | · | 245,077 Direct | +14.26% | Acquired | (price as of 2026-10-06) |
| May 7, 2014 | SCYX | C | 42,336 | · | · | 214,495 Direct | +24.59% | Acquired | (price as of 2026-10-06) |
| May 7, 2014 | SCYX | C | 88,796 | · | · | 172,159 Direct | +106.52% | Acquired | (price as of 2026-10-06) |
| May 7, 2014 | SCYX | C | 46,863 | · | · | 83,363 Direct | +128.39% | Acquired | (price as of 2026-10-06) |
| May 7, 2014 | SCYX | X | 25,998 | $0.20 | $5,200 | 36,500 Direct | +247.55% | Acquired | -69.8% (price as of 2026-10-06) |
| May 7, 2014 | SCYX | X | 5,251 | $0.20 | $1,050 | 10,502 Direct | +100.00% | Acquired | -69.8% (price as of 2026-10-06) |
| May 7, 2014 | SCYX | X | 5,251 | $0.20 | $1,050 | 5,251 Direct | · | Acquired | -69.8% (price as of 2026-10-06) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| May 7, 2014 | SCYX | Series D-2 Preferred Stock | Common Stock | · | · | 623,880 | Disposed |
| May 7, 2014 | SCYX | Series D-1 Preferred Stock | Common Stock | · | · | 863,672 | Disposed |
| May 7, 2014 | SCYX | Series C Preferred Stock | Common Stock | · | · | 313,996 | Disposed |
| May 7, 2014 | SCYX | Series B Preferred Stock | Common Stock | · | · | 166,482 | Disposed |
| May 7, 2014 | SCYX | Common Stock Warrant (right to buy) | Common Stock | $0.20 | Dec. 10, 2018 | 25,998 | Disposed |
| May 7, 2014 | SCYX | Common Stock Warrant (right to buy) | Common Stock | $0.20 | May 14, 2017 | 5,251 | Disposed |
| May 7, 2014 | SCYX | Common Stock Warrant (right to buy) | Common Stock | $0.20 | Dec. 6, 2016 | 5,251 | Disposed |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 7 holdings
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| May 2, 2014 | SCYX | Common Stock Warrant (right to buy) | 5,251 | Direct |
| May 2, 2014 | SCYX | Common Stock Warrant (right to buy) | 5,251 | Direct |
| May 2, 2014 | SCYX | Common Stock Warrant (right to buy) | 25,998 | Direct |
| May 2, 2014 | SCYX | Series B Preferred Stock | · | Direct |
| May 2, 2014 | SCYX | Series C Preferred Stock | · | Direct |
| May 2, 2014 | SCYX | Series D-1 Preferred Stock | · | Direct |
| May 2, 2014 | SCYX | Series D-2 Preferred Stock | · | Direct |